GENE ONLINE|News &
Opinion
Blog

Feature
BIO Asia 2021 Highlights: Realizing The Promise of Cell and Gene Therapies
2021-08-02
Germline Editing in Marsupials Marks Another Milestone for CRISPR
2021-08-01
The Evolution of Cytokine Therapies for a Broad Spectrum of Disorders
2021-07-30
Aridis Pharmaceuticals’ Antibody Shows Early Promise in the Fight Against COVID-19
2021-07-28
Reprogrammed CRISPR Tool Could Target Emerging SARS-CoV-2 Variants
2021-07-28
AI in Healthcare: Current Uses and The Need of the Hour to Accelerate Adoption
2021-07-27
What are Investors Looking for in a Biotech Startup?
2021-07-27
BIO Asia-Taiwan Opening Day Highlights: Michael Houghton Talks About Vaccine Development, Robert Langer Shares Journey of Creating Breakthrough Technologies
2021-07-27
Genetics Does Influence the Gut Microbiome, Long Term Research Reveals
2021-07-19
Aftermath of Biogen’s Alzheimer’s Drug Approval Continues as Some Hospitals, Insurers Refuse Administration
2021-07-18
COVID-19: FDA Adds New Warning For a Rare Autoimmune Disorder to J&J’s Vaccine
2021-07-14
COVID-19: Foxconn and TSMC Closes Deal to Secure 10 Million Pfizer Vaccines for Taiwan
2021-07-13
WHO Recommends the Use of Sanofi’s and Roche’s Rheumatoid Arthritis Drugs to Cut COVID-19 Deaths
2021-07-12
FDA Okays Bayer’s Kidney Disease Drug, Kicking Off Market Rivalry Against Established SGLT-2 Inhibitors
2021-07-12
Moderna Looks Beyond COVID as it Doses First Patient With mRNA-Based Seasonal Flu Vaccine
2021-07-09
1 33 34 35 36 37 60
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top